Professor Gilbert Department of Radiology, University of Cambridge, is focused on imaging techniques relating to breast cancer and oncology. She works in Addenbrookes Hospital and is part of the Cambridge Breast Unit which delivers screening to Cambridge & Huntingdon. She evaluates new imaging technology and is currently working on Artificial Intelligence in Imaging to detect cancer, biomarkers to predict cancer and response to neoadjuvant therapy, novel imaging techniques such as sodium imaging with MRI and assessing different imaging tools to detect cancer in women with dense breasts.
She is a regular speaker at international Radiology conferences in Chicago and Vienna and was awarded Honorary membership of Radiological Society of North America in 2019, Honorary fellowship of the American College of Radiologists, the Gold Medal from the European Society of Radiology and fellowship of the Royal Society of Edinburgh in 2021 and fellowship of the Academy of Medical Sciences. She is immediate past President of the European Society of Breast Imaging. She is the Lead advisor for AI for the Royal College of Radiologists.
She has sat on a number of committees and funding Boards and is on a number of advisory panels. She is a director of NASCIT. Previous appointments have been a Board member of the Royal Scottish National Orchestra, Governor of Robert Gordons College and vice chairman of the Beatson cancer charity.
Title: AI in breast cancer screening
Retrospective studies and Systematic reviews have demonstrated that there are a number of commercial AI tools ready for use in both 2D mammography and Digital Breast Tomosynthesis. The published prospective studies show promising results and the impact on interval cancers is awaited. These results will be discussed and together with the relevance to UK practice. The UK NIHR has commissioned a national trial of AI in the breast screening programme and the proposed study will be presented.